Rapport Therapeutics Offers Convertible Senior Notes Due 2032
Rapport Therapeutics disclosed an offering of convertible senior notes due 2032; the offering size was not disclosed.
Rapport Therapeutics disclosed an offering of convertible senior notes due 2032; the offering size was not disclosed.